There were 360 press releases posted in the last 24 hours and 442,591 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GSK and MMV announce FDA Breakthrough Therapy designation for tafenoquine for Plasmodium vivax malaria

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image